Comments
Loading...

AbCellera Biologics

ABCLNASDAQ
Logo brought to you by Benzinga Data
$2.99
-0.04-1.32%
At close: -
$2.98
-0.01-0.38%
After Hours: 5:45 PM EDT
Q4 2024 Earnings in 3 days from now on Thu Feb 27th, after the market close
Conference call scheduled in 3 days at 17:00 PM Click to view the webcast

AbCellera Biologics (NASDAQ:ABCL) Stock Quotes, Forecast and News Summary

AbCellera Biologics Stock (NASDAQ: ABCL) stock price, news, charts, stock research, profile.

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
1
Nov 24
1
Jan
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.4
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
Open$3.03
Close$2.99
Volume / Avg.5.62M / 3.35M
Day Range$2.89 - $3.04
52 Wk Range2.34 - 5.26
Market Cap$879.81M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
44
Short Interest
8.1%
Days to Cover4.67
About AbCellera Biologics Inc
Sector
Health Care
Industry
Life Sciences Tools & Services
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
ABCL
TXG

FAQ

Q

How do I buy AbCellera Biologics (ABCL) stock?

A

You can purchase shares of AbCellera Biologics (NASDAQ:ABCL) through any online brokerage.

View our list of the best stock brokerages

Q

Who are AbCellera Biologics (ABCL) competitors?

Q

What is the forecast, or price target, for AbCellera Biologics (ABCL) stock?

A

AbCellera Biologics has a consensus price target of $21.00.

Q

What is the current price for AbCellera Biologics (ABCL)?

A

The stock price for AbCellera Biologics (NASDAQ: ABCL) is $2.9787 last updated February 24, 2025 at 5:45 PM EST.

Q

Does AbCellera Biologics (ABCL) pay a dividend?

A

There are no upcoming dividends for AbCellera Biologics.

Q

When is AbCellera Biologics (NASDAQ:ABCL) reporting earnings?

A

AbCellera Biologics’s Q1 earnings are confirmed for Tuesday, May 6, 2025.

Q

Is AbCellera Biologics (ABCL) going to split?

A

There is no upcoming split for AbCellera Biologics.

Q

What sector and industry does AbCellera Biologics (ABCL) operate in?

A

AbCellera Biologics is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.

People Also Watch